Fig. 1
Forest plots of RORs for DAS 28 and CDAI for the assessment of low disease activity for comparisons of IL-6 inhibitors versus placebo (A) or active controls (B)
Fig. 1 | BMC Rheumatology
Forest plots of RORs for DAS 28 and CDAI for the assessment of low disease activity for comparisons of IL-6 inhibitors versus placebo (A) or active controls (B)